Impact of the COVID-19 pandemic on the care of cancer patients in Spain.
Impact of the COVID-19 pandemic on the care of cancer patients in Spain.
复制标题
共同-19大流行对西班牙癌症患者的护理的影响。
DOI：
10.1016/j.esmoop.2021.100157
复制
发表时间：
2021-06
期刊：
影响因子：
7.3
通讯作者：
Paz-Ares L
中科院分区：
文献类型：
--
作者：
Amador M;Matias-Guiu X;Sancho-Pardo G;Contreras Martinez J;de la Torre-Montero JC;Peñuelas Saiz A;Garrido P;García-Sanz R;Rodríguez-Lescure Á;Paz-Ares L
评估COVID-19大流行对公共医疗系统影响的研究有限，尤其是在癌症管理方面。由于西班牙尚未进行此类研究，我们的目标是描述和量化COVID-19大流行在第一波大流行期间对西班牙医院癌症患者的影响。这项回顾性、多中心、全国性研究收集了治疗肿瘤患者的医院科室的信息。使用了一份电子问卷，比较了2019年3月至6月和2020年3月至6月期间血液肿瘤患者的结局和管理。分析了78个部门（36家三级医院）的信息。2020年3月，44个部门实施了经调整的协议。其中大多数（n = 38/44; 86.4%）进行了COVID-19分诊，而44人中有26人（59.1%）对临床疑似病例进行了现场聚合酶链反应检测。在44个部门中，有43个部门（97.7%）从亲自访问转变为电话访问。与2019年3月至6月及2020年3月至6月期间相比，新症患者人数减少20. 8%（由160. 2人减少至126. 4人）。总活检（2858.2 vs. 1686.1）和癌症活检（465.5 vs. 367.2）的平均数量以及骨髓活检的平均数量（30.5 vs. 18.6）也有所减少。就前往特定癌症护理部门的患者人数而言，化疗治疗（712. 7对643. 8）及放射治疗（2169. 9对2139. 9）的平均次数较二零一九年至二零二零年有所减少。最后，从2019年到2020年，纳入临床试验的平均患者人数减少了12.9%（从8.6减少到7.4）。这项研究提供了关于COVID-19对西班牙癌症护理影响的第一个全面数据。疫情导致新诊断患者减少20.8%，可能影响未来结果。必须采取措施，确保癌症管理在医疗紧急情况下得到优先考虑。新增癌症患者人数减少20.8%调整援助方案纳入临床试验人数减少12.9%
Studies evaluating the effects of the COVID-19 pandemic on public healthcare systems are limited, particularly in cancer management. As no such studies have been carried out in Spain, our objective is to describe and quantify the impact of the COVID-19 pandemic on cancer patients in Spanish hospitals during the first wave of the pandemic. This retrospective, multicenter, nationwide study collected information from hospital departments treating oncology patients. An electronic questionnaire comparing outcomes and management of oncohematological patients for the March-June 2019 and March-June 2020 periods was used. Information from 78 departments (36 tertiary hospitals) was analyzed. Forty-four departments implemented adapted protocols during March 2020. Most of these (n = 38/44; 86.4%) carried out COVID-19 triage, while 26 of 44 (59.1%) carried out onsite polymerase chain reaction tests for clinically suspected cases. A shift from in-person to telephone visits was observed in 43 of 44 (97.7%) departments. Comparing the March-June 2019 and March-June 2020 periods, the number of new patients decreased by 20.8% (from 160.2 to 126.4). Decreases were also seen in the mean number of total (2858.2 versus 1686.1) and cancer (465.5 versus 367.2) biopsies, as well as the mean number of bone marrow biopsies (30.5 versus 18.6). Concerning the number of patients visiting specific cancer care departments, a decrease from 2019 to 2020 was seen for mean number of chemotherapy treatments (712.7 versus 643.8) and radiation therapy (2169.9 versus 2139.9). Finally, a reduction from 2019 to 2020 of 12.9% (from 8.6 to 7.4) in the mean number of patients included in clinical trials was noted. This study provides the first comprehensive data concerning the impact of COVID-19 on cancer care in Spain. The pandemic caused a 20.8% decrease in newly diagnosed patients, which may impact future outcomes. Measures must be taken to ensure cancer management receives priority in times of healthcare emergencies. The number of new cancer patients decreased 20.8% Assistance protocols were adapted Inclusion in clinical trials decreased by 12.9%
登录
查看更多内容
影响因子：
8.8
作者：
McPhail, S.;Johnson, S.;Greenberg, D.;Peake, M.;Rous, B.
通讯作者：
Rous, B.
影响因子：
4.5
作者：
Jazieh AR;Akbulut H;Curigliano G;Rogado A;Alsharm AA;Razis ED;Mula-Hussain L;Errihani H;Khattak A;De Guzman RB;Mathias C;Alkaiyat MOF;Jradi H;Rolfo C;International Research Network on COVID-19 Impact on Cancer Care
通讯作者：
International Research Network on COVID-19 Impact on Cancer Care
影响因子：
13.8
作者：
Rosenthal N;Cao Z;Gundrum J;Sianis J;Safo S
通讯作者：
Safo S
影响因子：
3.4
作者：
Rogado, J.;Obispo, B.;Lara, M. A.
通讯作者：
Lara, M. A.
DOI：
10.1038/s41571-020-00441-5
发表时间：
2021-01
期刊：
Nature reviews. Clinical oncology
影响因子：
--
作者：
Horn L;Garassino M
通讯作者：
Garassino M